Your browser doesn't support javascript.
loading
Boosting γδ T cell-mediated antibody-dependent cellular cytotoxicity by PD-1 blockade in follicular lymphoma.
Rossi, Cédric; Gravelle, Pauline; Decaup, Emilie; Bordenave, Julie; Poupot, Mary; Tosolini, Marie; Franchini, Don-Marc; Laurent, Camille; Morin, Renaud; Lagarde, Jean-Michel; Ysebaert, Loïc; Ligat, Laetitia; Jean, Christine; Savina, Ariel; Klein, Christian; Céspedes, Alba Matas; Perez-Galan, Patricia; Fournié, Jean-Jacques; Bezombes, Christine.
Afiliação
  • Rossi C; Centre de Recherches en Cancérologie de Toulouse (CRCT), UMR1037 INSERM, Université Toulouse III: Paul-Sabatier, ERL5294 CNRS, Université de Toulouse, Toulouse, France.
  • Gravelle P; Laboratoire d'Excellence TOUCAN, Toulouse, France.
  • Decaup E; Programme Hospitalo-Universitaire en Cancérologie CAPTOR, Toulouse, France.
  • Bordenave J; CALYM Carnot Institute, Pierre-Bénite, France.
  • Poupot M; CHU Dijon, Hématologie clinique, Hôpital François Mitterand, Dijon, France.
  • Tosolini M; Centre de Recherches en Cancérologie de Toulouse (CRCT), UMR1037 INSERM, Université Toulouse III: Paul-Sabatier, ERL5294 CNRS, Université de Toulouse, Toulouse, France.
  • Franchini DM; Laboratoire d'Excellence TOUCAN, Toulouse, France.
  • Laurent C; Programme Hospitalo-Universitaire en Cancérologie CAPTOR, Toulouse, France.
  • Morin R; CALYM Carnot Institute, Pierre-Bénite, France.
  • Lagarde JM; Department of Pathology, Institut Universitaire du Cancer de Toulouse, Toulouse, France.
  • Ysebaert L; Centre de Recherches en Cancérologie de Toulouse (CRCT), UMR1037 INSERM, Université Toulouse III: Paul-Sabatier, ERL5294 CNRS, Université de Toulouse, Toulouse, France.
  • Ligat L; Centre de Recherches en Cancérologie de Toulouse (CRCT), UMR1037 INSERM, Université Toulouse III: Paul-Sabatier, ERL5294 CNRS, Université de Toulouse, Toulouse, France.
  • Jean C; Laboratoire d'Excellence TOUCAN, Toulouse, France.
  • Savina A; Programme Hospitalo-Universitaire en Cancérologie CAPTOR, Toulouse, France.
  • Klein C; CALYM Carnot Institute, Pierre-Bénite, France.
  • Céspedes AM; Centre de Recherches en Cancérologie de Toulouse (CRCT), UMR1037 INSERM, Université Toulouse III: Paul-Sabatier, ERL5294 CNRS, Université de Toulouse, Toulouse, France.
  • Perez-Galan P; Laboratoire d'Excellence TOUCAN, Toulouse, France.
  • Fournié JJ; Programme Hospitalo-Universitaire en Cancérologie CAPTOR, Toulouse, France.
  • Bezombes C; CALYM Carnot Institute, Pierre-Bénite, France.
Oncoimmunology ; 8(3): 1554175, 2019.
Article em En | MEDLINE | ID: mdl-30723586
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Qualitative_research Idioma: En Revista: Oncoimmunology Ano de publicação: 2019 Tipo de documento: Article País de afiliação: França País de publicação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Qualitative_research Idioma: En Revista: Oncoimmunology Ano de publicação: 2019 Tipo de documento: Article País de afiliação: França País de publicação: Estados Unidos